D-1360-2020 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- July 8, 2020
- Initiation Date
- June 12, 2020
- Termination Date
- September 24, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,906 Cartons
Product Description
Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61
Reason for Recall
CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.
Distribution Pattern
Nationwide USA
Code Information
Lot T-02134, exp 09/2020